Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Stream Capital hires Katherine Hill for increasing secondary private equity demand

Monday, May 13, 2013
Opalesque Industry Update – Stream Capital SA has hired Katherine Hill as Director covering secondary alternative investment fund transfers for their Geneva office. Katherine will be responsible for secondary transactions of hedge funds and private equity funds with a focus on secondary directs and will also be part of the firm’s expansion into capital raising for alternative funds.

Katherine has been working in the hedge fund industry for over 10 years in both New York and Geneva and was most recently with Private Capital Consulting. Prior to this, she has worked as a consultant with Palladio Alternative Research as well as a senior hedge fund analyst at the family office Saad Financial Services. Katherine has an MBA from Fordham University in New York City and a BS from the University of Maryland.

“As we are growing and acquiring more market share in the secondary market sphere, we are very pleased that Katherine has joined our team,” says Stream Capital founder Robert JC Leach. “She brings a wealth of experience within the private equity secondary market.”

Stream Capital is an independent advisory and execution firm specialising in secondary transfers of investments in hedge funds, private equity and real estate funds. Founded in 2010 and based in Geneva, Switzerland, the firm is also active in capital raising for alternative funds.

Press release

www.streamcapital.ch

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its